Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Capital Stock and Other Capital (Less Treasury Stock)
QFRD326385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
297,565.00
Year-over-Year Change
-6.02%
Date Range
10/1/2000 - 4/1/2025
Summary
This economic indicator tracks the capital stock and other capital (less treasury stock) for U.S. pharmaceutical and medicine corporations on a quarterly basis. It provides critical insight into the financial structure and investment capacity of a key sector in the American economy.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The metric represents the net equity value of pharmaceutical corporations, reflecting their total capital resources after accounting for treasury stock. Economists use this data to assess sector financial health, investment potential, and corporate financial strategies.
Methodology
Data is collected through comprehensive quarterly financial reports submitted by pharmaceutical corporations to regulatory agencies.
Historical Context
This trend is used by investors, policymakers, and financial analysts to evaluate the pharmaceutical sector's economic performance and investment landscape.
Key Facts
- Represents net equity value for pharmaceutical corporations
- Quarterly data provides dynamic view of sector financial health
- Excludes treasury stock to show true capital resources
FAQs
Q: What does 'capital stock less treasury stock' mean?
A: It represents the total equity value of a corporation after subtracting shares repurchased by the company. This provides a more accurate picture of available capital.
Q: Why is this data important for pharmaceutical companies?
A: It helps investors and analysts understand the financial strength and investment capacity of pharmaceutical corporations. Higher capital indicates potential for research, development, and expansion.
Q: How often is this data updated?
A: The data is updated quarterly, providing a current snapshot of the pharmaceutical sector's financial landscape. This allows for timely analysis and decision-making.
Q: Can this trend predict sector performance?
A: While not a definitive predictor, changes in capital stock can signal potential shifts in corporate strategy, investment potential, and overall sector health.
Q: What limitations exist in this data?
A: The metric provides a financial snapshot but doesn't capture all nuances of corporate performance. It should be used alongside other financial indicators for comprehensive analysis.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Miscellaneous Manufacturing: Total Current Liabilities
QFRTCL339USNO
Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Short-Term Debt, Original Maturity of 1 Year or Less: Loans from Banks
QFR301385USNO
Quarterly Financial Report: U.S. Corporations: Motion Picture and Sound Recording Industries: Total Assets
QFR223512USNO
Quarterly Financial Report: U.S. Corporations: All Other Chemicals: Net Income Retained in Business
QFRNIRB325USNO
Quarterly Financial Report: U.S. Corporations: Plastics and Rubber Products: Other Direct Credits (Charges) to Retained Earnings (Net)
QFRD122326USNO
Quarterly Financial Report: U.S. Corporations: All Manufacturing: Cash Dividends Charged to Retained Earnings This Quarter
QFR120MFGUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Capital Stock and Other Capital (Less Treasury Stock) [QFRD326385USNO], retrieved from FRED.
Last Checked: 8/1/2025